We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.94%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$76.2B
AUM Growth
+$2.6B
(+3.5%)
Cap. Flow
-$2.97B
Cap. Flow
% of AUM
-3.9%
Top 10 Holdings %
Top 10 Hldgs %
21.61%
Holding
3,238
New
235
Increased
684
Reduced
2,065
Closed
243
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$77.3M |
| 2 |
Blackstone
BX
|
+$53.2M |
| 3 |
NXP Semiconductors
NXPI
|
+$40.8M |
| 4 |
Palantir
PLTR
|
+$34.3M |
| 5 |
Snowflake
SNOW
|
+$24.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$206M |
| 2 |
Microsoft
MSFT
|
+$163M |
| 3 |
Linde
LIN
|
+$133M |
| 4 |
Amazon
AMZN
|
+$94.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$82.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.34% |
| 2 | Financials | 14.16% |
| 3 | Healthcare | 12.95% |
| 4 | Consumer Discretionary | 12.06% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
2451
HomeTrust Bancshares
HTB
$850M
| $631K | ﹤0.01% |
22,613
-3,681
| -14% | -$101K |
|
|
MRNS
2452
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $630K | ﹤0.01% |
35,107
+9,131
| +35% | +$147K |
|
2453
PureCycle Technologies
PCT
$1.45B
| $629K | ﹤0.01% |
+26,604
| New | +$573K |
|
2454
Miller Industries
MLR
$619M
| $627K | ﹤0.01% |
15,905
-2,503
| -14% | -$107K |
|
2455
AXT Inc
AXTI
$5.8B
| $626K | ﹤0.01% |
56,968
-6,674
| -10% | -$70.8K |
|
2456
Kartoon Studios
TOON
$34.9M
| $626K | ﹤0.01% |
+34,049
| New | +$595K |
|
|
ICPT
2457
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $626K | ﹤0.01% |
31,353
+500
| +2% | +$9.91K |
|
|
SGFY
2458
DELISTED
Signify Health, Inc.
SGFY
| $622K | ﹤0.01% |
20,441
+3,678
| +22% | +$101K |
|
|
AKRO
2459
DELISTED
Akero Therapeutics
AKRO
| $621K | ﹤0.01% |
25,026
+11,376
| +83% | +$320K |
|
2460
Globalstar
GSAT
$10.7B
| $621K | ﹤0.01% |
+23,265
| New | +$456K |
|
2461
Turning Point Brands
TPB
$1.74B
| $621K | ﹤0.01% |
13,569
+1,444
| +12% | +$66.8K |
|
2462
Bar Harbor Bankshares
BHB
$666M
| $620K | ﹤0.01% |
21,654
-3,499
| -14% | -$103K |
|
2463
Equity Bancshares
EQBK
$1.05B
| $617K | ﹤0.01% |
20,220
-2,937
| -13% | -$89.9K |
|
2464
IDEAYA Biosciences
IDYA
$3.56B
| $616K | ﹤0.01% |
29,371
+10,763
| +58% | +$221K |
|
2465
Nkarta
NKTX
$172M
| $615K | ﹤0.01% |
19,402
-1,468
| -7% | -$42.3K |
|
2466
West Bancorporation
WTBA
$485M
| $615K | ﹤0.01% |
22,169
-3,205
| -13% | -$85.8K |
|
|
APPH
2467
DELISTED
AppHarvest, Inc. Common Stock
APPH
| $615K | ﹤0.01% |
+38,459
| New | +$614K |
|
2468
Bank of Marin Bancorp
BMRC
$459M
| $614K | ﹤0.01% |
19,245
-3,006
| -14% | -$105K |
|
|
ALBO
2469
DELISTED
Albireo Pharma Inc
ALBO
| $614K | ﹤0.01% |
17,459
-1,307
| -7% | -$42.5K |
|
|
ORC
2470
Orchid Island Capital
ORC
$1.31B
| $613K | ﹤0.01% |
23,626
+560
| +2% | +$15.6K |
|
|
CLVS
2471
DELISTED
Clovis Oncology, Inc.
CLVS
| $612K | ﹤0.01% |
105,572
+4,044
| +4% | +$23.7K |
|
2472
American Superconductor
AMSC
$1.59B
| $611K | ﹤0.01% |
35,143
-2,500
| -7% | -$40K |
|
|
TCRR
2473
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $611K | ﹤0.01% |
37,249
+375
| +1% | +$7.58K |
|
2474
Boston Omaha
BOC
$436M
| $610K | ﹤0.01% |
19,243
+2,458
| +15% | +$71.4K |
|
|
BRY
2475
DELISTED
Berry Corp
BRY
| $610K | ﹤0.01% |
90,825
-13,666
| -13% | -$86.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2021 Portfolio in Review
As of Q2 2021, RhumbLine Advisers held 3,238 positions worth $76.2B, up 3.5% from $73.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
RhumbLine Advisers withdrew a net $2.97B in Q2 2021, closing 243 positions and reducing 2,065 holdings. Its most notable exit was Varian Medical Systems, Inc., an estimated $32.1M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in DraftKings worth $14.2M.
- RhumbLine Advisers's largest Q2 2021 buy was DraftKings: 271,227 shares worth $14.2M.
- RhumbLine Advisers added most to iShares Core S&P 500 ETF in Q2 2021, an estimated $77.3M increase.
- RhumbLine Advisers's biggest Q2 2021 reduction was Apple, cutting an estimated $206M.
- RhumbLine Advisers fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $32.1M.
- RhumbLine Advisers's ten largest holdings make up 22% of its $76.2B portfolio in Q2 2021.
- RhumbLine Advisers opened 235 new positions and closed 243 in Q2 2021.
- RhumbLine Advisers's portfolio value rose 3.5% quarter-over-quarter to $76.2B.
Based on RhumbLine Advisers's 13F filing for Q2 2021, filed 5 Aug 2021.